INTERNATIONAL PATENT: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE TOURS, UNIVERSITE DE TOURS, UNIVERSITE DE MONTPELLIER, INSTITUT DU CANCER DE MONTPELLIER FILES APPLICATION FOR "ANTIBODIES TARGETING TRANS-ACTIVE RESPONSE DNA-BINDING PROTEIN-43 (TDP-43)"

GENEVA, Dec. 22 -- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 Paris), CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE TOURS (2 Boulevard Tonnelle37000 Tours), UNIVERSITE DE TOURS (60 rue du Plat d'Etain,37020 Tours Cedex 1), UNIVERSITE DE MONTPELLIER (163, rue Auguste Broussonnet34090 Montpellier), INSTITUT DU CANCER DE MONTPELLIER (Parc Euromedecine 208 Avenue des Apoticaires34090 Montpellier) filed a patent application (PCT/EP2025/066110) for "ANTIBODIES TARGETING TRANS-ACTIVE RESPONSE DNA-BINDING PROTEIN-43 (TDP-43)" on Jun 10, 2025. With publication no. WO/2025/257181, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under th...